Joshua D. Tompkins

1.0k total citations
19 papers, 469 citations indexed

About

Joshua D. Tompkins is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Joshua D. Tompkins has authored 19 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Joshua D. Tompkins's work include Epigenetics and DNA Methylation (7 papers), DNA Repair Mechanisms (6 papers) and CRISPR and Genetic Engineering (6 papers). Joshua D. Tompkins is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), DNA Repair Mechanisms (6 papers) and CRISPR and Genetic Engineering (6 papers). Joshua D. Tompkins collaborates with scholars based in United States, India and Canada. Joshua D. Tompkins's co-authors include Arthur D. Riggs, Chengtao Her, Xiling Wu, Charles Warden, Xiwei Wu, Patricia L. Foster, Yate‐Ching Yuan, Jeffrey D. Stumpf, Heehyoung Lee and Xiaojin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Joshua D. Tompkins

18 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua D. Tompkins United States 11 389 120 54 40 39 19 469
Feng-Tao Shi China 14 422 1.1× 66 0.6× 71 1.3× 23 0.6× 36 0.9× 18 633
Germain Margall-Ducos France 6 330 0.8× 201 1.7× 56 1.0× 83 2.1× 55 1.4× 6 538
Yuehua Gong China 12 232 0.6× 122 1.0× 79 1.5× 55 1.4× 32 0.8× 13 464
Amy L. Stark United States 14 237 0.6× 82 0.7× 71 1.3× 23 0.6× 86 2.2× 29 423
Stacey Jamieson Australia 9 266 0.7× 147 1.2× 77 1.4× 36 0.9× 50 1.3× 10 510
Tarryn Willmer South Africa 10 200 0.5× 49 0.4× 50 0.9× 30 0.8× 47 1.2× 18 300
Núria Palau Spain 10 143 0.4× 61 0.5× 33 0.6× 31 0.8× 40 1.0× 13 307
Aymen Shatnawi United States 10 210 0.5× 82 0.7× 57 1.1× 17 0.4× 44 1.1× 21 355
Chie Yamaguchi Japan 6 340 0.9× 57 0.5× 35 0.6× 23 0.6× 59 1.5× 6 418
Gregory Miles United States 5 199 0.5× 46 0.4× 117 2.2× 28 0.7× 88 2.3× 5 345

Countries citing papers authored by Joshua D. Tompkins

Since Specialization
Citations

This map shows the geographic impact of Joshua D. Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua D. Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua D. Tompkins more than expected).

Fields of papers citing papers by Joshua D. Tompkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua D. Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua D. Tompkins. The network helps show where Joshua D. Tompkins may publish in the future.

Co-authorship network of co-authors of Joshua D. Tompkins

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua D. Tompkins. A scholar is included among the top collaborators of Joshua D. Tompkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua D. Tompkins. Joshua D. Tompkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mooney, Rachael, Zhen Chen, Tristan Scott, et al.. (2025). Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease. Biomolecules. 15(7). 1000–1000. 2 indexed citations
2.
Tompkins, Joshua D., et al.. (2025). Cardiac repair and regeneration: cell therapy, in vivo reprogramming, and the promise of extracellular vesicles. Experimental & Molecular Medicine. 57(10). 2182–2200.
3.
Tompkins, Joshua D.. (2023). Transgenerational Epigenetic DNA Methylation Editing and Human Disease. Biomolecules. 13(12). 1684–1684. 5 indexed citations
4.
Tompkins, Joshua D., Xiwei Wu, Jonas Cerneckis, et al.. (2023). Engineering CpG island DNA methylation in pluripotent cells through synthetic CpG-free ssDNA insertion. Cell Reports Methods. 3(5). 100465–100465. 3 indexed citations
5.
Tompkins, Joshua D.. (2022). Discovering DNA Methylation, the History and Future of the Writing on DNA. Journal of the History of Biology. 55(4). 865–887. 13 indexed citations
6.
Chen, Zhuo, Barbara H. Braffett, John M. Lachin, et al.. (2020). DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes. Nature Metabolism. 2(8). 744–762. 66 indexed citations
7.
Reisinger, Michael, Joshua D. Tompkins, Arthur D. Riggs, et al.. (2020). G-Quadruplex Helicase DHX36/G4R1 Engages Nuclear Lamina Proteins in Quiescent Breast Cancer Cells. ACS Omega. 5(38). 24916–24926. 2 indexed citations
8.
Awasthi, Sanjay, Joshua D. Tompkins, Jyotsana Singhal, et al.. (2018). Rlip depletion prevents spontaneous neoplasia in TP53 null mice. Proceedings of the National Academy of Sciences. 115(15). 3918–3923. 26 indexed citations
9.
Tompkins, Joshua D., Marc Jung, Ziguang Lin, et al.. (2016). Mapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation “Memories”. EBioMedicine. 4. 74–85. 33 indexed citations
10.
Figarola, James L., Jyotsana Singhal, Joshua D. Tompkins, et al.. (2015). SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells. Journal of Biological Chemistry. 290(51). 30321–30341. 33 indexed citations
11.
Tompkins, Joshua D. & Arthur D. Riggs. (2014). An epigenetic perspective on the failing heart and pluripotent-derived-cardiomyocytes for cell replacement therapy. Frontiers in Biology. 10(1). 11–27. 7 indexed citations
12.
Warden, Charles, Heehyoung Lee, Joshua D. Tompkins, et al.. (2013). COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis. Nucleic Acids Research. 41(11). e117–e117. 87 indexed citations
13.
Wu, Xiling, et al.. (2013). MutS Homologue hMSH5: Recombinational DSB Repair and Non-Synonymous Polymorphic Variants. PLoS ONE. 8(9). e73284–e73284. 8 indexed citations
14.
Tompkins, Joshua D., Xiling Wu, & Chengtao Her. (2012). MutS homologue hMSH5: role in cisplatin-induced DNA damage response. Molecular Cancer. 11(1). 10–10. 21 indexed citations
15.
Wu, Xiling, et al.. (2012). Assessment of Anti-recombination and Double-strand Break-induced Gene Conversion in Human Cells by a Chromosomal Reporter. Journal of Biological Chemistry. 287(35). 29543–29553. 10 indexed citations
16.
Tompkins, Joshua D., et al.. (2012). Epigenetic stability, adaptability, and reversibility in human embryonic stem cells. Proceedings of the National Academy of Sciences. 109(31). 12544–12549. 44 indexed citations
17.
Tompkins, Joshua D., et al.. (2009). Evidence for a direct involvement of hMSH5 in promoting ionizing radiation induced apoptosis. Experimental Cell Research. 315(14). 2420–2432. 21 indexed citations
18.
Yi, Wei, et al.. (2006). Physical and Functional Interaction between hMSH5 and c-Abl. Cancer Research. 66(1). 151–158. 21 indexed citations
19.
Tompkins, Joshua D., et al.. (2003). Error-Prone Polymerase, DNA Polymerase IV, Is Responsible for Transient Hypermutation during Adaptive Mutation in Escherichia coli. Journal of Bacteriology. 185(11). 3469–3472. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026